Maiwald Magazine

News and Releases

Maiwald Blog

Paris, Munich, Milan – first revision of the UPCA adopted

It has been agreed upon for several weeks and was already confirmed at the meeting of the Administrative Committee of the Unified Patent Court (UPC)

Continue reading

Maiwald is pleased to be a member of the UPCLA network

What is the UPCLA network? The UPCLA network, created in 2014, is a non-exclusive network of European law...

Continue reading

To use or not to use – the nuisance of repeated trademark filings

The so-called grace period for use in the EU Trademark Regulation is intended to give applicants the opportunity to protect their trademark and thus an important marketing too...

Continue reading

查看所有条目

Press Articles

Another success for Maiwald and betapharm Arzneimittel GmbH

We are happy to report that the oppositions filed by our client betapharm and eight other generics manufacturers against Novartis patent EP 3 351 246 were successful; the Board of Appeal of the European Patent Office revoked the Novartis patent for lack of inventive step (fi...

Continue reading

Another success for Maiwald and betapharm Arzneimittel GmbH

We are happy to report that the oppositions filed by our client betapharm and eight other generics manufacturers against Novartis patent EP 3 351 246 were successful; the Board of Appeal of the European Patent Office revoked the Novartis patent for lack of inventive step (fi...

Continue reading

Novartis Fingolimod patent declared invalid by Federal Patent Court in first instance

At the end of June, the Federal Patent Court declared a Novartis patent (EP 3 143 990 B1) null and void in its entirety for lack of inventive step (file no. : 3 Ni 13/22). Novartis ma...

Continue reading

Maiwald in the press

Staff News

Maiwald congratulates on passing the exam

We would like to congratulate Dr Matthias Hoffmann and

Continue reading

Maiwald appoints Martina Boidol as partner

Maiwald, one of Germany's leading IP law firms, has appointed Martina Boidol...

Continue reading

Maiwald congratulates on passing the exam

We are very happy to congratulate Dr Quirin Spiller and

Continue reading

European Unitary Patent Package: Introduction to the New System including Strategic Considerations, (September 2023) 133 Intellectual Property Forum 40

The creation of the unitary patent and the Unified Patent Court (“UPC”) heralds the beginning of a new era in patent law in Europe. The Agreement on a Unified Patent Court...

Continue reading

Ergänzende Schutzzertifikate für Arzneimittel, EuZW 2023, 643

On April 27, 2023, the European Commission presented four proposals for Regulations on supplementary protection certificates as part of the Intellectual Property Action Plan. ...

Continue reading

Awards

FOCUS List of Top Commercial Law Firms in Germany 2023

This year, FOCUS presented Germany's top commercial law firms for the eleventh time in a row. We are delighted that we were able to convince and belong to the top commerci...

Continue reading

IP STARS Top Tier Firm rankings 2023 for patent disputes and protection work

We are very delighted to be once again recognized by Managing IP (MIP) as "Top Tier Firm" in the IP STARS Ranking 2023. By being awarded in the categories "Patent Prosecution ...

Continue reading

All awards

Events

BioTechX Europe 2023

BioTechX Europe is Europe’s largest congress covering diagnostics, precision medicine and digital transformation in pharmaceutical development and healthcare. In 2023 the 3-day event will return to Basel, the pharma hub of Europe, this time with 2500 leaders in the field, 450 speakers and 100 start-ups all under one ro...

Continue reading

Life Sciences Strategy Summit in IP & Exclusivity

We are pleased to be a Gold Sponsor of the Life Sciences Strategy Summit in IP & Exclusivity. Dr Eva Ehlich and Dr Annelie Wünsche will be speaking at a roundtable on "Freedom to Operate - Analysi...

Continue reading

All events